Chai Discovery

Chai Discovery is a biotechnology company based in San Francisco, CA, founded in 2024. The company specializes in using advanced artificial intelligence for molecular design, particularly in drug discovery and therapeutic development. Chai Discovery has developed AI models that predict and reprogram interactions between biochemical molecules, significantly enhancing the drug discovery process. The company offers two main products: Chai-1, a multi-modal foundation model for predicting molecular structures, and Chai-2, an advanced model for designing fully *de novo* antibodies with a high success rate. These tools are designed to streamline the drug discovery timeline, making it faster and more efficient. Chai Discovery targets the biotechnology and pharmaceutical sectors, aiming to collaborate with companies and researchers focused on innovative drug development. With a small team and substantial funding, the company is positioned to make a significant impact in the field of molecular biology.